While injectable medications have dominated the weight loss space for years, most people aren’t exactly pumped to stick a needle in their stomach on a weekly basis.

The approval of Novo’s Wegovy pill gives the drugmaker a first-mover ‍advantage in ​the race for a potent oral weight-loss medicine, as it tries to claw back market share from Lilly and compounding ma...

According to Novo Nordisk, a 64-week clinical trial with over 300 participants found that those with obesity or overweight who took the oral Wegovy pill once a day lost an average of 16.6% of their bo...